Editor’s Note: It’s understandable that fewer American patriots are as concerned about Covid-19 and the so-called “vaccines” today than they were just a couple of months ago, but it’s important that we continue to spread the truth because I assure you the powers-that-be are not done with medical tyranny, nor have they given up on poisoning the people, as this article demonstrates. This article was originally published by The Defender — Children’s Health Defense’s News & Views Website.
An analysis published earlier this month in Pediatrics concluded the COVID-19 mRNA vaccines are safe and effective in preschool-age children — a conclusion trumpeted by media outlets such as Parents and Medscape.
But the study, conducted by Kaiser Permanente researchers with funding from the Centers for Disease Control and Prevention (CDC), raises more questions than it answers.
Researchers followed children (mostly 4 years old or younger) who collectively received more than 245,000 doses of either the Pfizer or Moderna mRNA products and “found no indications of serious side effects,” according to a Kaiser Permanente news release.
Using a form of surveillance monitoring known as rapid cycle analysis, investigators performed weekly sequential analyses for 19 safety signals, including myocarditis, pericarditis, seizures, heart attack, Bell’s palsy, neurological inflammatory conditions, anaphylaxis and several others. The study period was from June 2022 to March 2023.
Instead of using a comparable group of unvaccinated children as the control, the authors compared adverse events occurring 1-21 days after vaccination in one group, with outcomes among children in another group who had received the shot at some point between 22 and 42 days previously.
Time since inoculation was the only distinguishing feature, and the only factor that might account for inter-group differences.
The study, therefore, boils down to the question of whether children who received an mRNA shot about 10 days previously experienced more or fewer adverse events than children who received their jab about 32 days previously.
Data were mined from the Vaccine Safety Datalink (VSD), a repository of patient data from eight private healthcare systems, which included five Kaiser Permanente regions and three other large health entities.
Up to three doses of the Pfizer-BioNTech product were given to 135,000 children, ages 6 months to 5 years, while 112,000 children, ages 6 months to 6 years, got the Moderna gene therapy.
Subject demographics more or less reflected the populations served by these healthcare companies.
The authors wrote that their safety surveillance over nine months “did not detect a safety signal for any outcome during the 21 days after vaccination. Importantly, no cases of myocarditis or pericarditis occurred after vaccination.”
The accompanying press release framed the conclusion even more positively. According to corresponding author Dr. Nicola Klein:
“Parents can be assured that this large study found no serious side effects from the mRNA vaccines. … Parents can protect their young children from COVID-19 in the same way they vaccinate their children to protect from other serious childhood diseases.”
Perhaps anticipating the long list of questions regarding their work, the researchers discussed the potential limitations of their analysis, which they said included:
- Reduced statistical power, particularly for rare outcomes.
- Low vaccine uptake in the evaluated age group (“only” 24.7% of the eligible population received at least one shot).
- Surveillance did not include “all potential safety concerns.”
And the kicker:
“We may have underestimated or missed potential safety concerns if the biologically plausible risk interval for an outcome differed from our specified risk interval.”
Together, the choice of control group and the time period selected almost guaranteed “reduced statistical power,” particularly when comparing the two groups.
In a 2022 paper Klein noted reports from “worldwide” sources of myocarditis/pericarditis after mRNA COVID-19 treatments “especially among younger male persons [italics mine] 0 to 7 days after receiving dose 2.”
Although the incidence of heart inflammation was low in the 0-5 age group for the Pfizer product (14.4 per million doses, mostly after the second shot), the incidence of serious cardiac events rose markedly for older groups. No data were available in the 2022 study for the Moderna shot.
For 18- to 29-year-old males — the youngest age group for which both Pfizer and Moderna data were available — Klein reported, based on VSD numbers, a cumulative myocarditis/pericarditis incidence of 135 cases per million for children who had received the two injections plus the booster.
For the Moderna product, the incidence was 185 per million. For females, the rates were about 10 per million for both mRNA shots.
Given the serious long-term consequences of heart inflammation, and its known occurrence among vaccinated teenagers and young adults, one wonders at the wisdom of giving mRNA shots to children who are even younger than those known to get sick from the treatments.
COVID-19 itself has been blamed for the rise in heart inflammation, but a search for data from very early in the pandemic, before this storyline emerged (possibly to hide the incidence of “vaccine” injuries), shows this to be a red herring.
A 2022 Italian study comparing myocarditis/pericarditis incidence pre- and post-COVID-19 reported that the annual incidence of myocarditis was significantly higher before the pandemic than during, with a rate of about 80 per million “pre” and 60 per million “during.”
The authors made a point to emphasize that “the incidence of myocarditis was significantly lower in COVID than in PRECOVID in the class of age 18-24 years” than for their general study population, which averaged 40 years of age.
The incidence of pericarditis was unchanged between the two time periods, at about 45 per million.
Comparing data from two far-flung studies should be undertaken with caution. However, the difference between a baseline of fewer than 60 cases per million for 18- to 24-year-old adults (the Italian study) and the 185 per million for “male persons” between 18 and 29 post-mRNA treatment (Klein et al.) clearly and inconveniently shatters the “safe and effective” narrative.
The lack of statistical power in Klein’s 2023 study, despite a very large “denominator” (total patients studied), is almost certainly due to the relatively small number of cases — which is exactly what one would expect when uncommon (but serious) side effects over such short time periods are compared.
True, this is an apples-to-apples comparison — but in this case, investigators pretty much used the exact same apples and reported their similarities as somehow noteworthy.
Klein’s data source(s) raise additional questions. Although the VSD is connected to the national Vaccine Adverse Event Reporting System (VAERS), how much of her raw data came from VAERS and how much came from VSD is unclear.
Eleven of VSD’s 13 participating commercial and academic hubs are “data reporting sites” whose contributions presumably include vaccine side effect reports.
The concern here is about motives and incentives. VAERS data are based mainly on self-reporting and are known to be gross underestimates of the actual number of incidents.
By contrast, hospitals and healthcare systems, e.g. those participating in VSD, were robustly incentivized to promote and administer the COVID-19 shots.
Along those lines, note that one author “received funding from Janssen Vaccines and Prevention for a study unrelated to coronavirus disease 2019 vaccines.” And lead investigator Klein “received grants from Pfizer for coronavirus disease 2019 vaccine clinical trials and from Merck, GSK, and Sanofi Pasteur for study work unrelated to the current study work.”
The rationale for immunizing children against COVID-19 has been hotly debated since the shots were first available to older adults in late 2020.
But by the time these treatments were authorized for children, it was already clear that kids do not get very sick from COVID-19 and are not a significant source of infection, either for the community or for “grandma” in her rocking chair at home.
As of early 2021, with the huge wave of Delta-variant fatalities in freefall, the number of U.S. pediatric COVID-19 deaths reported by the CDC was close to zero, both in terms of absolute cases and as a percentage of all deaths.
Yet in her interview with her institution’s media department, lead author Klein said:
“Even as the COVID-19 emergency has ended, we know that the coronavirus poses a long-term, serious threat to all ages, including children. Vaccinating children against COVID-19 benefits them by reducing the burden of illness, avoiding spreading the virus to family and others, and mitigating the small but real risk of serious illness.”
This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.
Two Storms, One Harvest
Every food crisis in living memory has been a one-shock event. The 2008 price spike was a commodity bubble. The 2020 shortages were a logistics failure. The 2022 grain scare was a war on one exporter’s ports. Each time, the system bent, adjusted, and recovered, and each time the experts assured us afterward that global markets are simply too big and too diversified to fail.
What nobody in Washington seems eager to discuss is that 2026 is shaping up to be something the modern food system has never actually faced. Two independent shocks, one climatic and one geopolitical, are converging on the same harvest cycle at the same time. Not sequentially. Simultaneously.
Start with the weather. The Pacific Ocean is currently building toward what forecasters now openly call a record event. NOAA’s Climate Prediction Center puts the odds of at least a strong El Niño near 88 percent, with roughly two in three odds it reaches “very strong” status, the tier reserved for perhaps three or four events in the entire satellite era. Every major global model now projects a median peak in Super El Niño territory, and most of them project it exceeding the 2015-16 event, which until now held the modern record. Sea surface anomalies were already brushing the super threshold in mid-July, months before these events normally peak. The atmosphere has already shifted into El Niño mode, and the event is forecast to crest in late fall and early winter.
This is not about “climate change.” It’s about the standard cycles of weather, and the cycle we’re currently in is one that has likely devastated societies in the past. We’re better prepared as a society today, but not all Americans are equally prepared.
Serious households have started doing the quiet math on their own. Grocery bills tell part of the story, and the forecast maps tell the rest, which is why long-term food storage has moved from fringe hobby to mainstream line item in the family budget, with established suppliers like Heaven’s Harvest seeing demand from people who five years ago would have rolled their eyes at the idea. That instinct is not paranoia. It is pattern recognition, and the pattern is worth walking through carefully.
Editor’s Note: Heaven’s Harvest IS a sponsor, but the warnings of this article are real and would be written even if we didn’t have a survival food sponsor. With that said, those who take advantage of what they offer can use promo code “Patriot” for 15% off.
The Fertilizer Clock Is Already Running
While the Pacific warms, the second shock has been unfolding in the Strait of Hormuz. The conflict with Iran turned the world’s most important energy chokepoint into a contested waterway, and the consequences reach far beyond the gas pump. Roughly a third of global fertilizer trade moves through Hormuz, and the disruption sent urea prices up 86 percent year over year by March, with a 53 percent jump in a single month.
The World Bank projects energy prices rising about 24 percent in 2026 and fertilizer about 31 percent. By its own accounting, fertilizer prices ran 35 percent higher in the first five months of this year than the same period last year.
Here is the mechanism the nightly news will not explain. Fertilizer is not a grocery item. It is a time-delayed input. The nitrogen a farmer in Iowa or Punjab could not afford to apply this spring does not show up as a problem this spring. It shows up as a thinner harvest six to twelve months later.
The World Bank’s own food security brief concedes that the effects of reduced applications earlier this season “are likely to become visible only later in harvest outcomes.” Translate that from institutional language into plain English and it means this. The damage is already done, it is already in the ground, and we are simply waiting for it to arrive on the shelf.
Now check the calendar. Six to twelve months from the spring planting season lands us squarely in late 2026 and early 2027. Which is precisely when the strongest El Niño in the instrumental record is forecast to peak, bringing its signature droughts to Southeast Asia, Australia, southern Africa, northern Brazil, and South Asia, the very regions that grow the world’s rice, sugar, and oilseeds.
The World Bank warns openly that a strong El Niño “could disrupt multiple crop belts simultaneously” on top of the conflict-driven input costs. Their baseline projection assumes the Middle East disruptions ease by autumn. What in the last two years of Middle East history suggests that assumption is safe?
The System Has No Slack Left
The comfortable answer is that global markets always adjust. But adjustment requires slack, and the slack is gone. Global cereal production is expected to decline from last year’s records even before El Niño does its work. The UN World Food Programme, hardly a den of right-wing preppers, is calling this the most significant disruption to its supply chains since Covid and the invasion of Ukraine, and its supply chain director put the stakes bluntly.
Today’s supply chain challenges are tomorrow’s hunger crisis.
There is also a political dimension that markets cannot price. When food gets scarce, governments do not behave like economists. They behave like politicians. Export bans, hoarding mandates, and panic buying at the national level turned the modest rice shortfall of 2008 into a global crisis, and analysts are already warning that import-dependent nations are the first dominoes.
The 2015-16 Super El Niño, a far weaker event than what is now forecast, threw tens of millions into food stress across Africa and Asia. This one is projected to be stronger, and it arrives with fertilizer already rationed by price and shipping lanes already contested by missiles.
What Joseph Knew
Scripture does not treat preparation for lean years as faithlessness. It treats it as wisdom delivered in advance to those willing to act on it.
Behold, there come seven years of great plenty throughout all the land of Egypt: And there shall arise after them seven years of famine; and all the plenty shall be forgotten in the land of Egypt.
Joseph did not respond to that warning with a hashtag or a committee. He stored grain during the years of abundance, and when the famine came, Egypt stood while its neighbors begged. The lesson is not that famine is certain. It is that the time to prepare is precisely when preparation still looks optional.
Nobody who filled a pantry in a year of plenty has ever regretted it, and nobody standing in an empty aisle has ever been glad he waited for certainty.
None of this calls for panic, and panic is the enemy of sound judgment anyway. It calls for the same unglamorous prudence our grandparents considered ordinary. Keep some cash margin, know your local growers, and put real food in deep storage while it is cheap and available, because the entire arc of this story is that cheap and available is a closing window.
Families looking for a straightforward place to start can visit Heaven’s Harvest and use promo code Patriot for 15 percent off long-term storable food. The forecasts may yet soften, the strait may yet reopen, and we should pray they do. But hope is a fine thing to hold and a foolish thing to eat.
